The Recombinant Proteins Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The rising prevalence and incidence of chronic illnesses, technological innovation, and expanding R&D investments by key companies are the primary drivers driving the growth of the recombinant proteins market. Increased awareness of chronic illnesses among the general public and governments is predicted to improve the market for recombinant goods. According to the World Health Organisation (WHO), chronic illnesses are the leading cause of mortality worldwide, accounting for over 60% of all fatalities.
The increased frequency of chronic illnesses is one of the major factors impacting the market. Diabetes, cancer, respiratory disorders, and cardiovascular disease are only a handful of the most common chronic diseases. According to Globocan forecasts, the number of cancer cases would rise from 19.3 million in 2020 to 24.6 million in 2030. Furthermore, by 2030, there will be 587 million diabetics globally. Chronic illnesses account for over 80% of mortality in middle- and low-income countries. Chronic illnesses are expected to affect more than 49% of the population in the U.S. by 2025. Strokes and heart problems account for 30% of all fatalities in the U.S.
What Questions Should You Ask before Buying a Market Research Report?
• How is the recombinant proteins market evolving?
• What is driving and restraining the recombinant proteins market?
• How will each recombinant proteins submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each recombinant proteins submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading recombinant proteins markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the recombinant proteins projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of recombinant proteins projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the recombinant proteins market?
• Where is the recombinant proteins market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the recombinant proteins market today, and over the next 10 years:
• Our 353-page report provides 146 tables and 248 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the recombinant proteins market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising recombinant proteins prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Product & Services Outlook
• Products
– Cytokines & Growth Factors: Interferons (IFNs), Interleukins (ILs), Others
– Antibodies
– Enzymes: Kinases Enzymes, Metabolic Enzymes, Others
– Recombinant Regulatory Protein
– Hormones
– Virus Antigens
– Immune Checkpoint Proteins
– Others
• Services
Application Outlook
• Biopharmaceutical Production
– Biologics
– Vaccines
– Cell & Gene Therapies
– Others
• Drug Discovery & Development
• Research
• Diagnostics
• Others
Host Cell Outlook
• Mammalian Systems
• Bacterial Cells
• Yeast & Fungi
• Insect Cells
• Others
End-user Outlook
• Biopharmaceutical and Biotechnology Companies
• CROs
• Academic & Research Institutes
• Diagnostic Laboratories
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Recombinant Proteins Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Abcam Plc
• Abnova Corporation
• Avantor Inc.
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Enzo Biochem Inc.
• GenScript
• Merck KGaA
• PerkinElmer, Inc.
• Proteintech Group, Inc.
• RayBiotech Life, Inc.
• Sino Biological Inc.
• STEMCELL Technologies
• Thermo Fisher Scientific Inc.
Overall world revenue for Recombinant Proteins Market, 2023 to 2033 in terms of value the market will surpass US$3,079.9 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Recombinant Proteins Market, 2023 to 2033 report help you?
In summary, our 350+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Recombinant Proteins Market, 2023 to 2033 Market, with forecasts for product & services, application, host cell, end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the Recombinant Proteins Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 14 of the major companies involved in the Recombinant Proteins Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Recombinant Proteins Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Recombinant Proteins Market Report 2023-2033: Forecasts by Products & Services (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILS), Others), Antibodies, Enzymes (Kinases Enzymes, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Virus Antigens, Immune Checkpoint Proteins, Others)), Services), by Application (Biopharmaceutical Production (Biologics, Vaccines, Cell & Gene Therapy, Others), Drug Discovery & Development, Research, Diagnostics, Others)), by Host Cell (Mammalian Systems, Bacterial Cells, Yeast & Fungi, Insect Cells, Others), by End-users (Biopharmaceutical and Biotechnology Companies, CROs, Academic & Research Institutes, Diagnostic Laboratories, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Recombinant Proteins Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Recombinant Products
3.2.1.2 High Funding for Biomedical Research
3.2.1.3 Increase in Number of Elderly Population will Drive the Market Growth
3.2.1.4 Patent Expiration for Biologics
3.2.2 Market Restraining Factors
3.2.2.1 Price Erosion of Recombinant Proteins
3.2.2.2 Stringent Regulation for Recombinant Proteins Production
3.2.3 Market Opportunities
3.2.3.1 Emerging Economies Expansion and Prioritisation of R&D
3.2.3.2 Growing Significance of Genomics and Proteomics
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors Impacting Recombinant Proteins Market
3.5.2 Economic Factors Impacting Recombinant Proteins Market
3.5.3 Social Factors Impacting Recombinant Proteins Market
3.5.4 Technological Factors Impacting Recombinant Proteins Market
4 Recombinant Proteins Market Analysis by Product & Services
4.1 Key Findings
4.2 Product & Services Segment: Market Attractiveness Index
4.3 Recombinant Proteins Market Size Estimation and Forecast by Product & Services
4.4 Products
4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Cytokines & Growth Factors
4.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.3.3 Interferons (IFNs)
4.4.3.4 Interleukins (ILs)
4.4.3.5 Others
4.4.4 Antibodies
4.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.5 Enzymes
4.4.5.1 Enzymes Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.5.2 Market Share by Region, 2023 & 2033 (%)
4.4.5.3 Kinases enzymes
4.4.5.4 Metabolic enzymes
4.4.5.5 Other Enzymes
4.4.6 Recombinant Regulatory Protein
4.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.6.2 Market Share by Region, 2023 & 2033 (%)
4.4.7 Hormones
4.4.7.1 Hormones Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.7.2 Market Share by Region, 2023 & 2033 (%)
4.4.8 Virus Antigens
4.4.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.8.2 Market Share by Region, 2023 & 2033 (%)
4.4.9 Immune Checkpoint Proteins
4.4.9.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.9.2 Market Share by Region, 2023 & 2033 (%)
4.4.10 Others
4.4.10.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.10.2 Market Share by Region, 2023 & 2033 (%)
4.5 Services
4.5.1 Service Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Recombinant Proteins Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Recombinant Proteins Market Size Estimation and Forecast by Application
5.4 Biopharmaceutical Production
5.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.4.3 Biologics
5.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.3.2 Market Share by Region, 2023 & 2033 (%)
5.4.4 Vaccines
5.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.4.2 Market Share by Region, 2023 & 2033 (%)
5.4.5 Cell & Gene Therapy
5.4.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.5.2 Market Share by Region, 2023 & 2033 (%)
5.4.6 Others
5.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.6.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Discovery & Development
5.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Research
5.6.1 Research Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Diagnostics
5.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Others
5.8.1 Others Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.8.2 Market Share by Region, 2023 & 2033 (%)
6 Recombinant Proteins Market Analysis by Host Cell
6.1 Key Findings
6.2 Host Cell Segment: Market Attractiveness Index
6.3 Recombinant Proteins Market Size Estimation and Forecast by Host Cell
6.4 Mammalian Systems
6.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Bacterial Cells
6.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Yeast & Fungi
6.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Insect Cells
6.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Others
6.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.8.2 Market Share by Region, 2023 & 2033 (%)
7 Recombinant Proteins Market Analysis by End-User
7.1 Key Findings
7.2 Recombinant Proteins Market Size Estimation and Forecast by End-User
7.3 Biopharmaceutical and Biotechnology Companies
7.3.1 Biopharmaceutical and Biotechnology Companies Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.3.2 Market Share by Region, 2023 & 2033 (%)
7.4 CROs
7.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Academic & Research Institutes
7.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Diagnostic Laboratories
7.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Others
7.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.7.2 Market Share by Region, 2023 & 2033 (%)
8 Recombinant Proteins Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Recombinant Proteins Market Analysis
9.1 Key Findings
9.2 North America Recombinant Proteins Market Attractiveness Index
9.3 North America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Recombinant Proteins Market Size Estimation and Forecast by Country
9.5 North America Recombinant Proteins Market Size Estimation and Forecast by Product &Services
9.6 North America Recombinant Proteins Market Size Estimation and Forecast by Product Type
9.7 North America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
9.8 North America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
9.9 North America Recombinant Proteins Market Size Estimation and Forecast by Application
9.10 North America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
9.11 North America Recombinant Proteins Market Size Estimation and Forecast by End-User
9.12 North America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
9.13 U.S. Recombinant Proteins Market Analysis
9.14 Canada Recombinant Proteins Market Analysis
10 Europe Recombinant Proteins Market Analysis
10.1 Key Findings
10.2 Europe Recombinant Proteins Market Attractiveness Index
10.3 Europe Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Recombinant Proteins Market Size Estimation and Forecast by Country
10.5 Europe Recombinant Proteins Market Size Estimation and Forecast by Product & Services
10.6 Europe Recombinant Proteins Market Size Estimation and Forecast by Product Type
10.7 Europe Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
10.8 Europe Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
10.9 Europe Recombinant Proteins Market Size Estimation and Forecast by Application
10.10 Europe Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
10.11 Europe Recombinant Proteins Market Size Estimation and Forecast by End-User
10.12 Europe Recombinant Proteins Market Size Estimation and Forecast by Host Cell
10.13 Germany Recombinant Proteins Market Analysis
10.14 UK Recombinant Proteins Market Analysis
10.15 France Recombinant Proteins Market Analysis
10.16 Italy Recombinant Proteins Market Analysis
10.17 Spain Recombinant Proteins Market Analysis
10.18 Russia Recombinant Proteins Market Analysis
10.19 Rest of Europe Recombinant Proteins Market Analysis
11 Asia Pacific Recombinant Proteins Market Analysis
11.1 Key Findings
11.2 Asia Pacific Recombinant Proteins Market Attractiveness Index
11.3 Asia Pacific Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Country
11.5 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product & services
11.6 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product Type
11.7 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
11.8 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
11.9 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Application
11.10 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
11.11 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Host Cell
11.12 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by End-User
11.13 Japan Recombinant Proteins Market Analysis
11.14 China Recombinant Proteins Market Analysis
11.15 India Recombinant Proteins Market Analysis
11.16 Australia Recombinant Proteins Market Analysis
11.17 South Korea Recombinant Proteins Market Analysis
11.18 Rest of Asia Pacific Recombinant Proteins Market Analysis
12 Latin America Recombinant Proteins Market Analysis
12.1 Key Findings
12.2 Latin America Recombinant Proteins Market Attractiveness Index
12.3 Latin America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product & Services
12.5 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product Type
12.6 Latin America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
12.7 Latin America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
12.8 Latin America Recombinant Proteins Market Size Estimation and Forecast by Application
12.9 Latin America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
12.10 Latin America Recombinant Proteins Market Size Estimation and Forecast by End-User
12.11 Latin America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
12.12 Brazil Recombinant Proteins Market Analysis
12.13 Mexico Recombinant Proteins Market Analysis
12.14 Argentina Recombinant Proteins Market Analysis
12.15 Rest of Latin America Recombinant Proteins Market Analysis
13 MEA Recombinant Proteins Market Analysis
13.1 Key Findings
13.2 MEA Recombinant Proteins Market Attractiveness Index
13.3 MEA Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Recombinant Proteins Market Size Estimation and Forecast by Country
13.5 MEA Recombinant Proteins Market Size Estimation and Forecast by Product & Services
13.6 MEA Recombinant Proteins Market Size Estimation and Forecast by Product Type
13.7 MEA Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
13.8 MEA Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
13.9 MEA Recombinant Proteins Market Size Estimation and Forecast by Application
13.10 MEA Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
13.11 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
13.12 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
13.13 GCC Recombinant Proteins Market Analysis
13.14 South Africa Recombinant Proteins Market Analysis
13.15 Rest of MEA Recombinant Proteins Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Abcam plc
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2017-2022
14.2.3.2 Regional Market Shares, 2022
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Bio-Techne
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 Research & Development, 2017-2022
14.3.3.3 Regional Market Shares, 2022
14.3.3.4 Segmental Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 GenScript
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.3.2 Regional Market Shares, 2022
14.4.3.3 Segmental Market Shares, 2021
14.4.4 Product Benchmarking
14.5 Bio-Rad Laboratories, Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2022
14.5.3.2 Regional Market Shares, 2022
14.5.3.3 Segmental Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Merck KGaA
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2022
14.6.3.2 Research & Development, 2017-2022
14.6.3.3 Regional Market Shares, 2022
14.6.3.4 Segmental Market Shares, 2022
14.6.4 Product Benchmarking
14.7 Thermo Fisher Scientific
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2022
14.7.3.2 Research and Development, 2017-2022
14.7.3.3 Regional Market Shares, 2022
14.7.3.4 Segmental Market Shares, 2022
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Enzo Biochem Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2022
14.8.3.2 Research & Development, 2017-2022
14.8.3.3 Regional Market Shares, 2022
14.8.3.4 Segmental Market Shares, 2022
14.8.4 Product Benchmarking
14.9 Sino Biological, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.10 Proteintech Group, Inc
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 Abnova Corporation
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.12 RayBiotech Life, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 STEMCELL Technologies
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 PerkinElmer Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2017-2022
14.14.3.2 Research & Development, 2017-2022
14.14.3.3 Regional Market Shares, 2022
14.14.3.4 Segmental Market Shares, 2022
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Avantor Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2022
14.15.3.2 Regional Market Shares, 2022
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
List of Tables
Table 1 Recombinant Proteins Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Product Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Cytokines & Growth Factors Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Interferons (IFNs)Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Interleukins (ILs) Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Antibodies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Kinases Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Metabolic Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Other Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Recombinant Regulatory Protein Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Hormones Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Virus Antigens Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Immune Checkpoint Proteins Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Service Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Biopharmaceutical production Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Biologics Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Cell & Gene Therapies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Drug Discovery & Development Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Research Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Diagnostics Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Mammalian Systems Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Bacterial Cells Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Yeast & Fungi Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Insect Cells Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Biopharmaceutical and Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 CROs Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Academic & Research Institutes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Diagnostic Laboratories Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Recombinant Proteins Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 46 North America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 North America Recombinant Proteins Market Forecast by Product &Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 North America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 North America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 North America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 North America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 North America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 North America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 North America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 U.S. Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Canada Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Europe Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Europe Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Europe Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Europe Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Europe Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Europe Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Europe Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Europe Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Europe Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Germany Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 UK Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 France Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Italy Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Spain Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 Russia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Europe Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 Asia Pacific Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Asia Pacific Recombinant Proteins Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Asia Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 Asia Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 Asia Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 Asia Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 Asia-Pacific Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 80 Asia Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 81 Asia Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 Japan Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 83 China Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 84 India Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 85 Australia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 86 South Korea Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 87 Rest of Asia Pacific Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 88 Latin America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 89 Latin America Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 90 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 91 Latin America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 92 Latin America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 93 Latin America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 94 Latin America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 95 Latin America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 96 Latin America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 97 Brazil Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 98 Mexico Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 99 Argentina Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 100 Rest of Latin America Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 101 MEA Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 102 MEA Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 103 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 104 MEA Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 105 MEA Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 106 MEA Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 107 MEA Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 108 MEA Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 109 MEA Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 110 GCC Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 111 South Africa Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 112 Rest of MEA Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 113 Abcam plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Abcam plc: Product Benchmarking
Table 115 Abcam plc: Strategic Outlook
Table 116 Bio-Techne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Bio-Techne.: Product Benchmarking
Table 118 Bio-Techne.: Strategic Outlook
Table 119 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 GenScript: Product Benchmarking
Table 121 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 123 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 124 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Merck KGaA: Product Benchmarking
Table 126 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Thermo Fisher Scientific: Product Benchmarking
Table 128 Thermo Fisher Scientific: Strategic Outlook
Table 129 Enzo Biochem Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Enzo Biochem Inc.: Product Benchmarking
Table 131 Sino Biological, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Sino Biological, Inc.: Product Benchmarking
Table 133 Proteintech Group, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Proteintech Group, Inc: Product Benchmarking
Table 135 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Abnova Corporation: Product Benchmarking
Table 137 RayBiotech Life, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 RayBiotech Life, Inc.: Product Benchmarking
Table 139 STEMCELL Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 STEMCELL Technologies: Product Benchmarking
Table 141 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 PerkinElmer Inc.: Product Benchmarking
Table 143 PerkinElmer Inc.: Strategic Outlook
Table 144 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 Avantor Inc.: Product Benchmarking
Table 146 Avantor Inc.: Strategic Outlook
List of Figures
Figure 1 Recombinant Proteins Market Segmentation
Figure 2 Recombinant Proteins Market by Products: Market Attractiveness Index
Figure 3 Recombinant Proteins Market Attractiveness Index by Region
Figure 4 Recombinant Proteins Market: Market Dynamics
Figure 5 NIH Program Level Budget
Figure 6 Global Population Aged 65+, 2022 (Unit Million)
Figure 7 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Recombinant Proteins Market: Porter’s Five Forces Analysis
Figure 12 Recombinant Proteins Market: PEST Analysis
Figure 13 Recombinant Proteins Market Forecast by Product & Services Market Attractiveness Index
Figure 14 Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 15 Recombinant Proteins Market Share Forecast by Product & Services, 2023, 2028, 2033 (%)
Figure 16 Product Market Forecast by Region, 2022-2033 (US$ Million)
Figure 17 Product Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Cytokines & Growth Factors Market Forecast by Region, 2023-2033 (US$ Million)
Figure 19 Cytokines & Growth Factors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Interferons (IFNs) Market Forecast by Region, 2023-2033 (US$ Million)
Figure 21 Interferons (IFNs) Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 interleukins (ILs)Market Forecast by Region, 2023-2033 (US$ Million)
Figure 23 interleukins (ILs)Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 25 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Antibodies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Antibodies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Enzymes Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Enzymes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Kinase Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Kinase Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Metabolic Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Metabolic Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Other Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 Other Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Recombinant Regulatory Protein Market Forecast by Region, 2023-2033 (US$ Million)
Figure 37 Recombinant Regulatory Protein Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Hormones Market Forecast by Region, 2023-2033 (US$ Million)
Figure 39 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Virus Antigens Market Forecast by Region, 2023-2033 (US$ Million)
Figure 41 Virus Antigens Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Immune Checkpoint Proteins Market Forecast by Region, 2023-2033 (US$ Million)
Figure 43 Immune Checkpoint Proteins Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 45 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Services Market Forecast by Region, 2023-2033 (US$ Million)
Figure 47 Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Recombinant Proteins Market Forecast by Application 2023, 2028, 2033 (Revenue, CAGR%)
Figure 49 Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 50 Recombinant Proteins Market Share Forecast by Application 2023, 2028, 2033 (%)
Figure 51 Biopharmaceutical Production Market Forecast by Region, 2023-2033 (US$ Million)
Figure 52 Biopharmaceutical production Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Biologics Market Forecast by Region, 2023-2033 (US$ Million)
Figure 54 Biologics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Vaccines Market Forecast by Region, 2023-2033 (US$ Million)
Figure 56 Vaccines Market Share Forecast by Region, 2023 & 2033 (%)
Figure 57 Cell & Gene Therapy Market Forecast by Region, 2023-2033 (US$ Million)
Figure 58 Cell & Gene Therapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 59 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 60 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 61 Drug Discovery & Development Market Forecast by Region, 2023-2033 (US$ Million)
Figure 62 Drug Discovery & Development Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 Research Market Forecast by Region, 2023-2033 (US$ Million)
Figure 64 Research Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Diagnostics Market Forecast by Region, 2023-2033 (US$ Million)
Figure 66 Diagnostics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 68 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Recombinant Proteins Market Forecast by Host Cell 2023, 2028, 2033 (Revenue, CAGR%)
Figure 70 Recombinant Proteins Market Forecast by Host Cells, 2023-2033 (US$ Million)
Figure 71 Recombinant Proteins Market Share Forecast by Host Cells, 2023, 2028, 2033 (%)
Figure 72 Mammalian System Market Forecast by Region, 2023-2033 (US$ Million)
Figure 73 Mammalian System Market Share Forecast by Region, 2023 & 2033 (%)
Figure 74 Bacterial Cells Market Forecast by Region, 2023-2033 (US$ Million)
Figure 75 Bacterial Cells Market Share Forecast by Region, 2023 & 2033 (%)
Figure 76 Yeast and Fungi Market Forecast by Region, 2023-2033 (US$ Million)
Figure 77 Yeast & Fungi Market Share Forecast by Region, 2023 & 2033 (%)
Figure 78 Insect Cells Market Forecast by Region, 2023-2033 (US$ Million)
Figure 79 Insect Cells Market Share Forecast by Region, 2023 & 2033 (%)
Figure 80 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 81 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 82 Recombinant Proteins Market Forecast by Therapeutics, 2023-2033 (US$ Million)
Figure 83 Recombinant Proteins Market Share Forecast by Therapeutics, 2023, 2028, 2033 (%)
Figure 84 Biopharmaceutical and Biotechnology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 85 Biopharmaceutical and Biotechnology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 86 CROs Market Forecast by Region, 2023-2033 (US$ Million)
Figure 87 CROs Market Share Forecast by Region, 2023 & 2033 (%)
Figure 88 Research Market Forecast by Region, 2023-2033 (US$ Million)
Figure 89 Academic & Research Institutes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 90 Diagnostics Laboratories Market Forecast by Region, 2023-2033 (US$ Million)
Figure 91 Diagnostics Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 92 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 93 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 94 Recombinant Proteins Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 95 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Figure 96 North America Recombinant Proteins Market Attractiveness Index
Figure 97 North America Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 98 North America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 99 North America Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 100 North America Recombinant Proteins Market Forecast by Products and Services, 2023-2033 (US$ Million)
Figure 101 North America Recombinant Proteins Market Share Forecast by Products and Services, 2023 & 2033 (%)
Figure 102 North America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 103 North America Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 104 North America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 105 North America Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 106 North America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 107 North America Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 108 North America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 109 North America Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 110 North America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 111 North America Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 112 North America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million)
Figure 113 North America Recombinant Proteins Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 114 North America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 115 North America Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 116 U.S. Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 Canada Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 Europe Recombinant Proteins Market Attractiveness Index
Figure 119 Europe Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 120 Europe Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 121 Europe Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 122 Europe Recombinant Proteins Market Forecast by Product and Services, 2023-2033 (US$ Million)
Figure 123 Europe Recombinant Proteins Market Share Forecast by Product and Services, 2023 & 2033 (%)
Figure 124 Europe Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 125 Europe Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 126 Europe Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million)
Figure 127 Europe Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors, 2023 & 2033 (%)
Figure 128 Europe Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 129 Europe Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 130 Europe Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 131 Europe Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 132 Europe Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 133 Europe Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 134 Europe Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million)
Figure 135 Europe Recombinant Proteins Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 136 Europe Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 137 Europe Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 138 Germany Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 UK Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 140 France Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 Italy Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 Spain Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 Russia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Rest of Europe Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 Asia Pacific Recombinant Proteins Market Attractiveness Index
Figure 146 Asia Pacific Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 147 Asia Pacific Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 148 Asia Pacific Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 149 Asia Pacific Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 150 Asia Pacific Recombinant Proteins Market Share Forecast by Product & Services, 2023 & 2033 (%)
Figure 151 Asia Pacific Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 152 Asia Pacific Recombinant Proteins Market Share Forecast by product type, 2023 & 2033 (%)
Figure 153 Asia Pacific Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 154 Asia Pacific Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 155 Asia Pacific Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 156 Asia Pacific Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 157 Asia Pacific Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 158 Asia Pacific Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 159 Asia Pacific Recombinant Proteins Market Forecast by Biopharmaceuticals Production, 2023-2033 (US$ Million)
Figure 160 Asia Pacific Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production, 2023 & 2033 (%)
Figure 161 Asia Pacific Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 162 Asia Pacific Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 163 Asia Pacific Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 164 Asia Pacific Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 165 Japan Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 166 China Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 167 India Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 168 Australia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 169 South Korea Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 170 Rest of Asia Pacific Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 171 Latin America Recombinant Proteins Market Attractiveness Index
Figure 172 Latin America Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 173 Latin America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 174 Latin America Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 175 Latin America Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 176 Latin America Recombinant Proteins Market Share Forecast by Product & Services, 2023 & 2033 (%)
Figure 177 Latin America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 178 Latin America Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 179 Latin America Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million)
Figure 180 Latin America Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors, 2023 & 2033 (%)
Figure 181 Latin America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 182 Latin America Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 183 Latin America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 184 Latin America Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 185 Latin America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 186 Latin America Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 187 Latin America Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 188 Latin America Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 189 Latin America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 190 Latin America Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 191 Brazil Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 192 Mexico Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 193 Argentina Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 194 Rest of Latin America Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 195 MEA Recombinant Proteins Market Attractiveness Index
Figure 196 MEA Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 197 MEA Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 198 MEA Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 199 MEA Recombinant Proteins Market Forecast by products & services , 2023-2033 (US$ Million)
Figure 200 MEA Recombinant Proteins Market Share Forecast by products & services, 2023 & 2033 (%)
Figure 201 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 202 MEA Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 203 MEA Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 204 MEA Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 205 MEA Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 206 MEA Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 207 MEA Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 208 MEA Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 209 MEA Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 210 MEA Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 211 MEA Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 212 MEA Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 213 MEA Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 214 MEA Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 215 GCC Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 216 South Africa Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 217 Rest of MEA Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 218 Recombinant Proteins Market: Company Share/Ranking, 2022
Figure 219 Abcam plc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 220 Abcam plc: Regional Market Shares, 2022
Figure 221 Bio-Techne.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 222 Bio-Techne.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 223 Bio-Techne.: Regional Market Shares, 2022
Figure 224 Bio-Techne.: Segmental Market Shares, 2022
Figure 225 GenScript: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 226 GenScript: Regional Market Shares, 2022
Figure 227 GenScript: Segmental Market Shares, 2021
Figure 228 Bio-Rad Laboratories, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 229 Bio-Rad Laboratories, Inc.: Regional Market Shares, 202
Figure 230 Bio-Rad Laboratories, Inc.: Segmental Market Shares, 2022
Figure 231 Merck KGaA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 232 Merck KGaA: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 233 Merck KGaA: Regional Market Shares, 2022
Figure 234 Merck KGaA: Segmental Market Shares, 2022
Figure 235 Thermo Fisher Scientific: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 236 Thermo Fisher Scientific: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 237 Thermo Fisher Scientific: Regional Market Shares, 2022
Figure 238 Thermo Fisher Scientific: Segmental Market Shares, 2022
Figure 239 Enzo Biochem Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 240 Enzo Biochem Inc.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 241 Enzo Biochem Inc.: Regional Market Shares, 2022
Figure 242 Enzo Biochem Inc.: Segmental Market Shares, 2022
Figure 243 PerkinElmer Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 244 PerkinElmer Inc.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 245 PerkinElmer Inc.: Regional Market Shares, 2022
Figure 246 PerkinElmer Inc.: Segmental Market Shares, 2022
Figure 247 Avantor Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 248 Avantor Inc.: Regional Market Shares, 2022
List of Companies Profiled in the Report
Abcam Plc
Abnova Corporation
Avantor Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne
Enzo Biochem Inc.
GenScript
Merck KGaA
PerkinElmer, Inc.
Proteintech Group, Inc.
RayBiotech Life, Inc.
Sino Biological Inc.
STEMCELL Technologies
Thermo Fisher Scientific Inc.
List of Other Companies Mentioned in the Report
AB Science
AbCellera Biologics Ltd.
Abingdon Health
Alamar Biosciences
Allston
Astellas Pharma
Aurinia Pharmaceuticals
AusBiotech
BioCertica
BioVision
Catamaran Bio
Cellectis
CiteAb
Creditas
Daiichi Sankyo
DBV Technologies
EcoVadis
Eisai Co., Ltd.
Elevian
Fintech
Flash
Jeito Capital
Kurma Partners
MindBeacon
Namocell, Inc.
NanoString Technologies, Inc.
Nautilus Biotechnology, Inc.
NuProbe USA
PeproTech
Pfizer
Pionyr Immunotherapeutics, Inc.
QIAGEN
Repare Therapeutics
Sironax
Sofinnova Partners
Taibang Biologic
Takeda
Think Research
Twist Bioscience Corporation
WuXiDiagnostics
List of Associations Mentioned in the Report
Australian Biotechnology Association
Center for Therapeutic Innovation (CTI)
Centers for Medicare and Medicaid Services
Department of Health and Social Care (DHSC)
Drugs Controller General of India (DCGI)
European Medicines Agency (EMA)
European Union (EU)
European Union for Health
Higher Education Innovation Funding (HEIF)
Hong Kong Stock Exchange (HKEX)
India Brand Equity Foundation (IBEF)
International Conferences on Harmonization (ICH)
International Diabetes Federation (IDF)
National Health Service (NHS)
National Institutes of Health (NIH)
US Food and Drug Administration (FDA)
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
